NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300,642 | +0.9% | 2,952 | 0.0% | 0.22% | +3.9% |
| Q2 2023 | $297,838 | +9.7% | 2,952 | 0.0% | 0.21% | +5.6% |
| Q1 2023 | $271,540 | +1.5% | 2,952 | +0.1% | 0.20% | -2.5% |
| Q4 2022 | $267,559 | +9.7% | 2,949 | -8.0% | 0.20% | -0.5% |
| Q3 2022 | $244,000 | -10.0% | 3,205 | -0.1% | 0.20% | -18.9% |
| Q2 2022 | $271,000 | -67.9% | 3,207 | -66.7% | 0.25% | +31.1% |
| Q1 2022 | $845,000 | +41.1% | 9,625 | +40.5% | 0.19% | +13.8% |
| Q4 2021 | $599,000 | -0.2% | 6,849 | -6.6% | 0.17% | -12.1% |
| Q3 2021 | $600,000 | +81.8% | 7,333 | +102.7% | 0.19% | -22.4% |
| Q2 2021 | $330,000 | +7.8% | 3,618 | +1.1% | 0.24% | -2.4% |
| Q1 2021 | $306,000 | -67.0% | 3,577 | -63.6% | 0.25% | -69.4% |
| Q4 2020 | $927,000 | – | 9,814 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |